Molecular Testing for Somatic Mutations Improves the Accuracy of Thyroid Fine‐needle Aspiration Biopsy

Abstract

Genetic testing for somatic mutations in thyroid FNA biopsy samples is feasible and identifies a subset of malignant thyroid neoplasms that are indeterminate or suspicious on FNA biopsy. Genetic testing for common somatic genetic alterations thus could allow for more definitive initial thyroidectomy in those with positive results.